Show simple item record

dc.contributor.authorJones, Claire
dc.contributor.authorBadger, Stephen A
dc.contributor.authorMcClements, Jane
dc.contributor.authorMcKie, Lloyd
dc.contributor.authorDiamond, Tom
dc.contributor.authorTaylor, Mark A
dc.date.accessioned2012-02-01T11:08:58Z
dc.date.available2012-02-01T11:08:58Z
dc.date.issued2012-02-01T11:08:58Z
dc.identifier.citationAnn R Coll Surg Engl. 2010 Mar;92(2):136-8.en_GB
dc.identifier.issn1478-7083 (Electronic)en_GB
dc.identifier.issn0035-8843 (Linking)en_GB
dc.identifier.pmid20353641en_GB
dc.identifier.doi10.1308/003588410X12628812458734en_GB
dc.identifier.urihttp://hdl.handle.net/10147/207846
dc.description.abstractINTRODUCTION: The National Health Service (NHS) Cancer Plan guidelines recommend a maximum 2-week wait from referral to first appointment, and 2 months from referral to treatment for primary cancers. However, there are currently no guidelines available for metastatic disease. In the UK, nearly half of all colorectal cancer patients develop hepatic metastases. Timely, surgical resection offers the potential for cure. The aim of this study was to audit current practice for colorectal liver metastases in a regional hepatobiliary unit, and compare this to the NHS Cancer Plan standards for primary disease. PATIENTS AND METHODS: A retrospective review of the unit's database was performed for all hepatic metastases referrals from January 2006 to December 2008. The dates of referral, first appointment, investigations and initiation of treatment, along with patient's age and sex, were recorded on Microsoft Excel and analysed. Time was expressed as mean +/- SD in days. RESULTS: A total of 102 patients with hepatic metastases were identified. Five were excluded due to incomplete data. The average time from referral to first appointment was 10.6 +/- 9.4 days and the average time from referral to treatment was 38.5 +/- 28.6 days. Seventy-five (72.7%) had surgical intervention, of whom 37 also had chemotherapy. CONCLUSIONS: The data compare favourably to the NHS Cancer Plan guidelines for primary malignancy, demonstrating that a regional hepatobiliary unit is capable of delivering a service for colorectal liver metastases that adheres to the NHS Cancer Plan. Therefore, the NHS Cancer Plan can be applied to this cohort.
dc.language.isoengen_GB
dc.subject.meshAgeden_GB
dc.subject.mesh*Colorectal Neoplasmsen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshGuideline Adherenceen_GB
dc.subject.meshHumansen_GB
dc.subject.meshLiver Neoplasms/*secondary/*surgeryen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMedical Auditen_GB
dc.subject.meshMiddle Ageden_GB
dc.subject.meshNorthern Irelanden_GB
dc.subject.meshPractice Guidelines as Topicen_GB
dc.subject.meshReferral and Consultation/standards/statistics & numerical dataen_GB
dc.subject.meshState Medicine/*standardsen_GB
dc.subject.meshTime Factorsen_GB
dc.subject.mesh*Waiting Listsen_GB
dc.titleCan the National Health Service Cancer Plan timeline be applied to colorectal hepatic metastases?en_GB
dc.contributor.departmentHepatobiliary Surgical Unit, Mater Hospital, Belfast, UK. cjones82@hotmail.co.uken_GB
dc.identifier.journalAnnals of the Royal College of Surgeons of Englanden_GB
dc.description.provinceLeinster
html.description.abstractINTRODUCTION: The National Health Service (NHS) Cancer Plan guidelines recommend a maximum 2-week wait from referral to first appointment, and 2 months from referral to treatment for primary cancers. However, there are currently no guidelines available for metastatic disease. In the UK, nearly half of all colorectal cancer patients develop hepatic metastases. Timely, surgical resection offers the potential for cure. The aim of this study was to audit current practice for colorectal liver metastases in a regional hepatobiliary unit, and compare this to the NHS Cancer Plan standards for primary disease. PATIENTS AND METHODS: A retrospective review of the unit's database was performed for all hepatic metastases referrals from January 2006 to December 2008. The dates of referral, first appointment, investigations and initiation of treatment, along with patient's age and sex, were recorded on Microsoft Excel and analysed. Time was expressed as mean +/- SD in days. RESULTS: A total of 102 patients with hepatic metastases were identified. Five were excluded due to incomplete data. The average time from referral to first appointment was 10.6 +/- 9.4 days and the average time from referral to treatment was 38.5 +/- 28.6 days. Seventy-five (72.7%) had surgical intervention, of whom 37 also had chemotherapy. CONCLUSIONS: The data compare favourably to the NHS Cancer Plan guidelines for primary malignancy, demonstrating that a regional hepatobiliary unit is capable of delivering a service for colorectal liver metastases that adheres to the NHS Cancer Plan. Therefore, the NHS Cancer Plan can be applied to this cohort.


This item appears in the following Collection(s)

Show simple item record